抗寄生虫的
抗寄生虫药
组合化学
化学
计算机科学
立体化学
生物
医学
药理学
病理
作者
Sovitj Pou,Rozalia A. Dodean,Lisa Frueh,Katherine M. Liebman,Rory T. Gallagher,Haihong Jin,Robert T. Jacobs,Aaron Nilsen,David R. Stuart,J. Stone Doggett,Michael K. Riscoe,Rolf W. Winter
标识
DOI:10.1021/acs.oprd.1c00099
摘要
The endochin-like quinolone (ELQ) compound class may yield effective, safe treatments for a range of important human and animal afflictions. However, to access the public health potential of this compound series, a synthetic route needed to be devised, which would lower costs and be amenable to large-scale production. In the new synthetic route described here, a substituted β-keto ester, formed by an Ullmann reaction and subsequent acylation, is reacted with an aniline via a Conrad–Limpach reaction to produce 3-substituted 4(1H)-quinolones such as ELQ-300 and ELQ-316. This synthetic route, the first described to be truly amenable to industrial-scale production, is relatively short (five reaction steps), does not require palladium, chromatographic separation, or protecting group chemistry, and may be performed without high vacuum distillation.
科研通智能强力驱动
Strongly Powered by AbleSci AI